These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Metabolomics Assay Identified a Novel Virulence-Associated Siderophore Encoded by the High-Pathogenicity Island in Uropathogenic Escherichia coli. Xu G; Guo H; Lv H J Proteome Res; 2019 May; 18(5):2331-2336. PubMed ID: 30994357 [TBL] [Abstract][Full Text] [Related]
8. The small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coli. Porcheron G; Habib R; Houle S; Caza M; Lépine F; Daigle F; Massé E; Dozois CM Infect Immun; 2014 Dec; 82(12):5056-68. PubMed ID: 25245805 [TBL] [Abstract][Full Text] [Related]
9. Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition. Reitzer L; Zimmern P Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31619395 [TBL] [Abstract][Full Text] [Related]
10. Virulence factors of uropathogenic E. coli and their interaction with the host. Lüthje P; Brauner A Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769 [TBL] [Abstract][Full Text] [Related]
11. Siderophore production by uropathogenic Escherichia coli. Vagrali MA Indian J Pathol Microbiol; 2009; 52(1):126-7. PubMed ID: 19136808 [TBL] [Abstract][Full Text] [Related]
12. The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence. Robinson AE; Heffernan JR; Henderson JP Future Microbiol; 2018 Jun; 13(7):745-756. PubMed ID: 29870278 [TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotyping of the Yersinia high-pathogenicity island that regulates central carbon metabolism. Yan L; Nie W; Lv H Analyst; 2015 May; 140(10):3356-61. PubMed ID: 25870861 [TBL] [Abstract][Full Text] [Related]
14. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. Yun KW; Kim HY; Park HK; Kim W; Lim IS J Microbiol Immunol Infect; 2014 Dec; 47(6):455-61. PubMed ID: 24064288 [TBL] [Abstract][Full Text] [Related]
15. Comments: Siderophore production by uropathogenic Escherichia coli. Gokarn K Indian J Pathol Microbiol; 2010; 53(3):570. PubMed ID: 20699532 [No Abstract] [Full Text] [Related]
16. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of virulence factors and phylogenetic characterization of uropathogenic Escherichia coli causing urinary tract infection in patients with and without diabetes mellitus. Harwalkar A; Gupta S; Rao A; Srinivasa H Trans R Soc Trop Med Hyg; 2015 Dec; 109(12):769-74. PubMed ID: 26567223 [TBL] [Abstract][Full Text] [Related]
18. Siderophore-Microcins in Massip C; Oswald E Front Cell Infect Microbiol; 2020; 10():381. PubMed ID: 32974212 [TBL] [Abstract][Full Text] [Related]
19. Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions. Stærk K; Khandige S; Kolmos HJ; Møller-Jensen J; Andersen TE J Infect Dis; 2016 Feb; 213(3):386-94. PubMed ID: 26290608 [TBL] [Abstract][Full Text] [Related]